Proteins of TNF-α and IL6 pathways are elevated in serum of type-1 diabetes patients with microalbuminuria

Sharad B Purohit, Ashok Kumar Sharma, Wenbo Zhi, Shan Bai, Diane Hopkins, Leigh Steed, Bruce Bode, Stephen W. Anderson, John Chip Reed, R. Dennis Steed, Jin-Xiong She

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Soluble cytokine receptors may play an important role in development of microalbuminuria (MA) in type-1 diabetes (T1D). In this study, we measured 12 soluble receptors and ligands from TNF-a/IL6/IL2 pathways in T1D patients with MA (n = 89) and T1D patients without MA (n = 483) participating in the PAGODA study. Twelve proteins in the sera from T1D patients with and without MA were measured using multiplex Luminex assays. Ten serum proteins (sTNFR1, sTNFR2, sIL2Ra, MMP2, sgp130, sVCAM1, sIL6R, SAA, CRP, and sICAM1) were significantly elevated in T1D patients with MA. After adjusting for age, duration of diabetes, and sex in logistic regression, association remained significant for seven proteins. MA is associated with increasing concentrations of all 10 proteins, with the strongest associations observed for sTNFR1 (OR = 108.3, P < 10-32) and sTNFR2 (OR = 65.5, P < 10-37), followed by sIL2Ra (OR = 12.9, P < 10-13), MMP2 (OR = 5.5, P < 10-6), sgp130 (OR = 5.2, P < 10-3), sIL6R (OR = 4.6, P < 10-4), and sVCAM1 (OR = 3.3, P < 10-4). We developed a risk score system based on the combined odds ratios associated with each quintile for each protein. The risk scores cluster MA patients into three subsets, each associated with distinct risk for MA attributable to proteins in the TNF-a/IL6 pathway (mean OR = 1, 13.5, and 126.3 for the three subsets, respectively). Our results suggest that the TNF-a/IL6 pathway is overactive in approximately 40% of the MA patients and moderately elevated in the middle 40% of the MA patients. Our results suggest the existence of distinct subsets of MA patients identifiable by their serum protein profiles.

Original languageEnglish (US)
Article number154
JournalFrontiers in immunology
Volume9
Issue numberJAN
DOIs
StatePublished - Jan 31 2018

Fingerprint

Type 1 Diabetes Mellitus
Interleukin-6
Serum
Proteins
Cytokine Receptor gp130
Blood Proteins
Tumor Necrosis Factors
Cytokine Receptors
Interleukin-2
Logistic Models
Odds Ratio

Keywords

  • Cytokine receptors
  • Cytokines
  • Diabetes
  • Inflammation
  • Microalbuminuria

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Proteins of TNF-α and IL6 pathways are elevated in serum of type-1 diabetes patients with microalbuminuria. / Purohit, Sharad B; Sharma, Ashok Kumar; Zhi, Wenbo; Bai, Shan; Hopkins, Diane; Steed, Leigh; Bode, Bruce; Anderson, Stephen W.; Reed, John Chip; Steed, R. Dennis; She, Jin-Xiong.

In: Frontiers in immunology, Vol. 9, No. JAN, 154, 31.01.2018.

Research output: Contribution to journalArticle

Purohit, Sharad B ; Sharma, Ashok Kumar ; Zhi, Wenbo ; Bai, Shan ; Hopkins, Diane ; Steed, Leigh ; Bode, Bruce ; Anderson, Stephen W. ; Reed, John Chip ; Steed, R. Dennis ; She, Jin-Xiong. / Proteins of TNF-α and IL6 pathways are elevated in serum of type-1 diabetes patients with microalbuminuria. In: Frontiers in immunology. 2018 ; Vol. 9, No. JAN.
@article{fa267fa2ed454419ad179196656b6f67,
title = "Proteins of TNF-α and IL6 pathways are elevated in serum of type-1 diabetes patients with microalbuminuria",
abstract = "Soluble cytokine receptors may play an important role in development of microalbuminuria (MA) in type-1 diabetes (T1D). In this study, we measured 12 soluble receptors and ligands from TNF-a/IL6/IL2 pathways in T1D patients with MA (n = 89) and T1D patients without MA (n = 483) participating in the PAGODA study. Twelve proteins in the sera from T1D patients with and without MA were measured using multiplex Luminex assays. Ten serum proteins (sTNFR1, sTNFR2, sIL2Ra, MMP2, sgp130, sVCAM1, sIL6R, SAA, CRP, and sICAM1) were significantly elevated in T1D patients with MA. After adjusting for age, duration of diabetes, and sex in logistic regression, association remained significant for seven proteins. MA is associated with increasing concentrations of all 10 proteins, with the strongest associations observed for sTNFR1 (OR = 108.3, P < 10-32) and sTNFR2 (OR = 65.5, P < 10-37), followed by sIL2Ra (OR = 12.9, P < 10-13), MMP2 (OR = 5.5, P < 10-6), sgp130 (OR = 5.2, P < 10-3), sIL6R (OR = 4.6, P < 10-4), and sVCAM1 (OR = 3.3, P < 10-4). We developed a risk score system based on the combined odds ratios associated with each quintile for each protein. The risk scores cluster MA patients into three subsets, each associated with distinct risk for MA attributable to proteins in the TNF-a/IL6 pathway (mean OR = 1, 13.5, and 126.3 for the three subsets, respectively). Our results suggest that the TNF-a/IL6 pathway is overactive in approximately 40{\%} of the MA patients and moderately elevated in the middle 40{\%} of the MA patients. Our results suggest the existence of distinct subsets of MA patients identifiable by their serum protein profiles.",
keywords = "Cytokine receptors, Cytokines, Diabetes, Inflammation, Microalbuminuria",
author = "Purohit, {Sharad B} and Sharma, {Ashok Kumar} and Wenbo Zhi and Shan Bai and Diane Hopkins and Leigh Steed and Bruce Bode and Anderson, {Stephen W.} and Reed, {John Chip} and Steed, {R. Dennis} and Jin-Xiong She",
year = "2018",
month = "1",
day = "31",
doi = "10.3389/fimmu.2018.00154",
language = "English (US)",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "JAN",

}

TY - JOUR

T1 - Proteins of TNF-α and IL6 pathways are elevated in serum of type-1 diabetes patients with microalbuminuria

AU - Purohit, Sharad B

AU - Sharma, Ashok Kumar

AU - Zhi, Wenbo

AU - Bai, Shan

AU - Hopkins, Diane

AU - Steed, Leigh

AU - Bode, Bruce

AU - Anderson, Stephen W.

AU - Reed, John Chip

AU - Steed, R. Dennis

AU - She, Jin-Xiong

PY - 2018/1/31

Y1 - 2018/1/31

N2 - Soluble cytokine receptors may play an important role in development of microalbuminuria (MA) in type-1 diabetes (T1D). In this study, we measured 12 soluble receptors and ligands from TNF-a/IL6/IL2 pathways in T1D patients with MA (n = 89) and T1D patients without MA (n = 483) participating in the PAGODA study. Twelve proteins in the sera from T1D patients with and without MA were measured using multiplex Luminex assays. Ten serum proteins (sTNFR1, sTNFR2, sIL2Ra, MMP2, sgp130, sVCAM1, sIL6R, SAA, CRP, and sICAM1) were significantly elevated in T1D patients with MA. After adjusting for age, duration of diabetes, and sex in logistic regression, association remained significant for seven proteins. MA is associated with increasing concentrations of all 10 proteins, with the strongest associations observed for sTNFR1 (OR = 108.3, P < 10-32) and sTNFR2 (OR = 65.5, P < 10-37), followed by sIL2Ra (OR = 12.9, P < 10-13), MMP2 (OR = 5.5, P < 10-6), sgp130 (OR = 5.2, P < 10-3), sIL6R (OR = 4.6, P < 10-4), and sVCAM1 (OR = 3.3, P < 10-4). We developed a risk score system based on the combined odds ratios associated with each quintile for each protein. The risk scores cluster MA patients into three subsets, each associated with distinct risk for MA attributable to proteins in the TNF-a/IL6 pathway (mean OR = 1, 13.5, and 126.3 for the three subsets, respectively). Our results suggest that the TNF-a/IL6 pathway is overactive in approximately 40% of the MA patients and moderately elevated in the middle 40% of the MA patients. Our results suggest the existence of distinct subsets of MA patients identifiable by their serum protein profiles.

AB - Soluble cytokine receptors may play an important role in development of microalbuminuria (MA) in type-1 diabetes (T1D). In this study, we measured 12 soluble receptors and ligands from TNF-a/IL6/IL2 pathways in T1D patients with MA (n = 89) and T1D patients without MA (n = 483) participating in the PAGODA study. Twelve proteins in the sera from T1D patients with and without MA were measured using multiplex Luminex assays. Ten serum proteins (sTNFR1, sTNFR2, sIL2Ra, MMP2, sgp130, sVCAM1, sIL6R, SAA, CRP, and sICAM1) were significantly elevated in T1D patients with MA. After adjusting for age, duration of diabetes, and sex in logistic regression, association remained significant for seven proteins. MA is associated with increasing concentrations of all 10 proteins, with the strongest associations observed for sTNFR1 (OR = 108.3, P < 10-32) and sTNFR2 (OR = 65.5, P < 10-37), followed by sIL2Ra (OR = 12.9, P < 10-13), MMP2 (OR = 5.5, P < 10-6), sgp130 (OR = 5.2, P < 10-3), sIL6R (OR = 4.6, P < 10-4), and sVCAM1 (OR = 3.3, P < 10-4). We developed a risk score system based on the combined odds ratios associated with each quintile for each protein. The risk scores cluster MA patients into three subsets, each associated with distinct risk for MA attributable to proteins in the TNF-a/IL6 pathway (mean OR = 1, 13.5, and 126.3 for the three subsets, respectively). Our results suggest that the TNF-a/IL6 pathway is overactive in approximately 40% of the MA patients and moderately elevated in the middle 40% of the MA patients. Our results suggest the existence of distinct subsets of MA patients identifiable by their serum protein profiles.

KW - Cytokine receptors

KW - Cytokines

KW - Diabetes

KW - Inflammation

KW - Microalbuminuria

UR - http://www.scopus.com/inward/record.url?scp=85041332720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041332720&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.00154

DO - 10.3389/fimmu.2018.00154

M3 - Article

AN - SCOPUS:85041332720

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - JAN

M1 - 154

ER -